Next Time You Buy Parmesan, Watch Out for the Microchip
What to Read Next Source link
Merck
U.S. Chamber of Commerce Challenges Federal Government’s New Drug-Price Powers
The lawsuit is the second filed this week saying Medicare’s new negotiating authority is unconstitutional. Source link
Merck Challenges U.S. Government’s New Powers to Negotiate Drug Prices
The drugmaker filed a lawsuit saying Medicare’s drug-price negotiation program violates the company’s constitutional rights. Source link
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
Moderna’s Earnings, Revenue Fall on Fewer Covid Vaccine Sales
Demand for its Covid-19 vaccine sank from year-earlier highs when the spread of the Omicron variant boosted sales. Source link
Why Many Cold Medicines Don’t Work to Relieve Congestion
HealthDoctors, pharmacists ask the FDA to stop the sale of versions of Benadryl, Mucinex, Theraflu and Tylenol after studies find...
Amgen Agrees to Deal to Buy Horizon Therapeutics
BusinessThe U.S. biotechnology company will pay $116.50 for each Horizon share Source link
Merck Is Coming for Pfizer’s Pneumonia Vaccine Market Share
HealthRivals’ interest in the $7 billion market shows the drug industry’s renewed focus on vaccines Source link
WSJ News Exclusive | Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer Inc. PFE -1.18% is in advanced talks to buy Global Blood Therapeutics Inc., GBT 33.03% the maker of a...
WSJ News Exclusive | Merck Deal for Seagen Seen as Unlikely by Earnings Release
Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized ahead of the pharmaceutical giant’s...
WSJ News Exclusive | Merck Explores Purchase of Biotech Seagen
Merck MRK -0.32% & Co. is eyeing a purchase of biotech Seagen Inc., SGEN 12.72% according to people familiar with...
New Covid-19 Pills Carry Risks: What Patients Should Know
The first Covid-19 antiviral pills that can be taken at home are a new treatment option for infected people, but...
FDA Authorizes Merck’s Covid-19 Pill for At-Home Treatment
U.S. regulators cleared use of a Covid-19 pill from Merck MRK -0.33% & Co. and partner Ridgeback Biotherapeutics LP, the...
Pfizer’s Covid-19 Pill Is Authorized in U.S.
U.S. health regulators cleared use of a Covid-19 pill from Pfizer Inc., the first drug that newly infected patients can...
Pfizer Submits Covid-19 Pill for FDA Authorization
Pfizer Inc. said it asked U.S. health regulators to authorize its oral Covid-19 drug for use in high-risk patients, putting...
Merck’s Covid-19 Pill Licensed to U.N.-Backed Nonprofit to Increase Global Supplies
Merck & Co. will license a promising Covid-19 drug to a United Nations-backed nonprofit to provide more supplies to low-...
Merck Asks FDA to Authorize Promising Covid-19 Pill
Merck & Co. and partner Ridgeback Biotherapeutics LP said Monday they have filed an application asking U.S. health regulators to...
Apple, Amazon, Tesla Among the Giants Set to Post Results
Corporate giants from Apple Inc. to Visa Inc. are expected to report their financial results over the coming week, giving...
U.S. to Invest More Than $3 Billion in Covid-19 Antiviral Development
WASHINGTON—The Biden administration will invest more than $3 billion on developing and manufacturing antiviral pills to treat coronavirus, the Department...
WSJ CEO Council Features Interviews With Janet Yellen, Jamie Dimon
The Wall Street Journal is hosting its CEO Council summit Tuesday with top executives, administration officials and policy experts, as...
